Statement of Deviation and Variation of Funds for q ended 31.03.2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sandu Pharmaceuticals submitted its quarterly fund utilization report covering three preferential share issues (private placements). Tranche 1 raised Rs 2.64 crore on 31-03-2021, Tranche 2 raised Rs 1.38 crore on 28-02-2022, and Tranche 3 raised Rs 1.32 crore on 14-07-2022. The company reported NO deviation or variation in the use of funds for all three tranches. Tranches 1 and 2 have been fully utilized (Rs 2.64 crore and Rs 1.38 crore respectively), while Tranche 3 shows partial utilization of Rs 43.35 lakh out of Rs 1.32 crore raised. Funds are deployed towards plant modernization, marketing infrastructure, civil works, machinery, and working capital. The Audit Committee reviewed and approved all statements with no auditor comments.
Positive signal for shareholders as all three fund raises are being used as intended with zero deviation reported. The partial utilization of Tranche 3 funds (Rs 88.59 lakh still unutilized in escrow/FD) indicates ongoing capital deployment rather than idle funds.